Enhanced Recovery Medication Strategies for Lumbar Surgery
(ERAS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how different medication strategies before spine surgery can improve patient recovery and reduce costs. It compares taking all medications orally with some administered intravenously (through an IV) for those undergoing lumbar spine surgery. The trial aims to determine which method aids faster and more comfortable recovery. Candidates for this trial include individuals undergoing lumbar spine surgery for 1 to 3 levels without certain medical complications. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, allowing participants to contribute to advancements in surgical recovery methods.
Do I need to stop my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both oral and intravenous medications used in Enhanced Recovery After Surgery (ERAS) plans have been well-tolerated in past studies. For the oral group, studies have found that taking medications like acetaminophen, celecoxib, tranexamic acid, and gabapentin before surgery aids recovery and reduces complications. This method has proven safe and effective for quicker recovery.
In the intravenous group, research supports the safety of medications like intravenous acetaminophen and tranexamic acid. Studies have shown that these effectively manage pain after surgery. Participants have generally tolerated these medications well, with no major side effects reported.
Overall, both oral and intravenous methods in ERAS plans have shown promising safety results. They aim to improve recovery and reduce pain after spine surgery, making them a potentially good option for those considering participation in a clinical trial.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the Enhanced Recovery Medication Strategies for Lumbar Surgery because they aim to improve pain management and recovery speed with innovative approaches. Unlike traditional protocols that primarily rely on intravenous pain medications post-surgery, this trial explores the use of oral pre-operative analgesics and a combination of oral and intravenous agents to potentially reduce opioid use and enhance recovery. Group A focuses on all oral medications, including acetaminophen, celecoxib, tranexamic acid, and gabapentin, which may offer a simpler and less invasive option. Meanwhile, Group B incorporates both oral and intravenous agents, with tranexamic acid delivered intravenously at the start of surgery, potentially providing more targeted pain control. These strategies could lead to quicker recovery times and reduced opioid dependency, which is a significant concern in current surgical care.
What evidence suggests that this trial's treatments could be effective for lumbar surgery recovery?
This trial will compare two medication strategies for lumbar surgery. Research has shown that taking pills before surgery, as in Group A: All oral pre-operative analgesics, can manage pain and reduce the need for additional painkillers after spine surgery. This approach may also lead to shorter hospital stays and fewer hospital returns due to pain. Conversely, Group B: Intravenous agents involves treatments given through an IV, which can reduce pain and nausea after spine surgery and lessen the need for more pain medicine afterward. Both methods aim to improve recovery by managing pain effectively and potentially lowering overall healthcare costs.678910
Who Is on the Research Team?
Rolando F Roberto, MD
Principal Investigator
Univeristy of California Davis Medical Center
Are You a Good Fit for This Trial?
This trial is for individuals scheduled for 1 to 3 level lumbar decompression and fusion surgeries. It's not suitable for cancer-related procedures, those who can't move around soon after surgery, spine trauma patients, or anyone with a history of blood clots or heart attacks that make it unsafe to use tranexamic acid.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Medication Administration
Participants receive either oral or intravenous medications prior to surgery
Surgery and Immediate Postoperative Care
Participants undergo elective orthopaedic spine surgery and immediate postoperative care
Follow-up
Participants are monitored for safety and effectiveness after surgery, including assessment of postoperative complications and patient-reported outcomes
What Are the Treatments Tested in This Trial?
Interventions
- All oral administration group
- Enhanced Recovery After Surgery
- Intravenous Infusion group
Enhanced Recovery After Surgery is already approved in European Union, United States, Canada, China for the following indications:
- Colorectal surgery
- Gynecologic surgery
- Orthopedic surgery
- Gastrointestinal surgery
- Gynecologic surgery
- Orthopedic surgery
- Gastrointestinal surgery
- Surgical oncology
- General surgery
- Orthopedic surgery
- Gastrointestinal surgery
- Gastrointestinal surgery
- Orthopedic surgery
- Gynecologic surgery
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor